The TS score is associated with tumor EMT, CSCs, tumor stromal cells, tumor immune infiltration, and TP53 mutation characteristics and is an efficient index for estimating TS and predicting prognosis and therapeutic responsiveness. Here, TP53 is linked to neoplasm.